Literature DB >> 9882714

Conformation of Fibronectin Fibrils Varies: Discrete Globular Domains of Type III Repeats Detected.

.   

Abstract

: Cryo-high-resolution scanning electron microscopy was used to analyze the conformation of fibronectin fibrils formed in human skin fibroblast cultures or in a cell-free system by treating soluble plasma fibronectin with guanidine. Structurally, fibrils assembled in the cell-free system and in culture were similar. Assembly of both fibrillar networks involves interactions with the III1 and amino terminal repeats of fibronectin; their conformations consist of either smooth surfaces or patches of smooth surfaces and nodules randomly spaced along the fibril. The random distribution of these two conformations in fibrils indicates that fibronectin fibrils are capable of undergoing localized conformational changes. The nodules may be discrete domains of 3 to 4 type III repeats, as they can be labeled with the monoclonal antibody IST-2 to the III13-14 repeats in fibronectin and are found in 160 kDa and 85 kDa fragments of fibronectin that only contain type III repeats. In our study, smooth regions of fibrils were never recognized by the IST-2 antibody, suggesting that the epitope in the III13-14 repeats is masked in these regions. These results demonstrate that fibronectin fibrils are flexible and certain epitopes of fibronectin may be buried, or exposed, depending on the conformation of the fibril. They also show that fibrils assembled in cell-free conditions can be a powerful tool for studying fibril formation.

Entities:  

Year:  1998        PMID: 9882714     DOI: 10.1017/s1431927698980369

Source DB:  PubMed          Journal:  Microsc Microanal        ISSN: 1431-9276            Impact factor:   4.127


  9 in total

1.  Stretch-dependent changes in molecular conformation in fibronectin nanofibers.

Authors:  John M Szymanski; Emily N Sevcik; Kairui Zhang; Adam W Feinberg
Journal:  Biomater Sci       Date:  2017-07-25       Impact factor: 6.843

2.  Assay to mechanically tune and optically probe fibrillar fibronectin conformations from fully relaxed to breakage.

Authors:  William C Little; Michael L Smith; Urs Ebneter; Viola Vogel
Journal:  Matrix Biol       Date:  2008-02-21       Impact factor: 11.583

3.  Fibers with integrated mechanochemical switches: minimalistic design principles derived from fibronectin.

Authors:  Orit Peleg; Thierry Savin; German V Kolmakov; Isaac G Salib; Anna C Balazs; Martin Kröger; Viola Vogel
Journal:  Biophys J       Date:  2012-11-07       Impact factor: 4.033

4.  Force-induced unfolding of fibronectin in the extracellular matrix of living cells.

Authors:  Michael L Smith; Delphine Gourdon; William C Little; Kristopher E Kubow; R Andresen Eguiluz; Sheila Luna-Morris; Viola Vogel
Journal:  PLoS Biol       Date:  2007-10-02       Impact factor: 8.029

5.  Studying early stages of fibronectin fibrillogenesis in living cells by atomic force microscopy.

Authors:  Tetyana Gudzenko; Clemens M Franz
Journal:  Mol Biol Cell       Date:  2015-09-15       Impact factor: 4.138

6.  Molecular architecture of native fibronectin fibrils.

Authors:  Susanna Maria Früh; Ingmar Schoen; Jonas Ries; Viola Vogel
Journal:  Nat Commun       Date:  2015-06-04       Impact factor: 14.919

7.  The ultrastructure of fibronectin fibers pulled from a protein monolayer at the air-liquid interface and the mechanism of the sheet-to-fiber transition.

Authors:  Maria Mitsi; Stephan Handschin; Isabel Gerber; Ruth Schwartländer; Enrico Klotzsch; Roger Wepf; Viola Vogel
Journal:  Biomaterials       Date:  2014-10-13       Impact factor: 12.479

8.  3D mapping of native extracellular matrix reveals cellular responses to the microenvironment.

Authors:  Zipora Lansky; Yael Mutsafi; Lothar Houben; Tal Ilani; Gad Armony; Sharon G Wolf; Deborah Fass
Journal:  J Struct Biol X       Date:  2019 Jan-Mar

9.  Using molecular mechanics to predict bulk material properties of fibronectin fibers.

Authors:  Mark J Bradshaw; Man C Cheung; Daniel J Ehrlich; Michael L Smith
Journal:  PLoS Comput Biol       Date:  2012-12-27       Impact factor: 4.475

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.